We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Angiographic Algorithm Facilitates Coronary Artery Assessment

By HospiMedica International staff writers
Posted on 29 May 2018
Innovative software can calculate pressure drop in the coronary artery non-invasively, obviating the need for a pressure wire and hyperemic agent.

The Pie Medical Imaging (Maastricht, The Netherlands) Cardiovascular Angiographic Analysis Systems for vessel Fractional Flow Reserve (CAAS vFFR) software module is designed to reconstruct a three-dimensional (3D) model of the vasculature using just two angiograms taken during a standard catheterization procedure in order to assess pressure drop, which is expressed as a vFFR value. More...
The 3D reconstruction also enables assessment of the severity and percentage of coronary artery stenosis.

For percutaneous coronary interventions (PCI), within one easy workflow, CAAS vFFR offers a unique combination of functional and anatomical lesion assessment to support the interventional cardiologist in the clinical decision making process. A recent study by researchers at Erasmus Medical Center (Rotterdam, the Netherlands) shows that CAAS vFFR has a high linear correlation to invasively measured FFR and high diagnostic accuracy. The study was presented at EuroPCR 2018, held during May 2018 in Paris (France).

“We are very proud of this technological and clinical achievement, which is the result of 30-year commitment and experience of our company in the field of cardiovascular analysis software, and of the successful collaboration with the most prestigious medical and scientific research centers,” said René Guillaume, CEO of PMI.

FFR is an established technique used in interventional cardiology to the hemodynamic severity of atherosclerotic narrowing of the coronary arteries. It specifically identifies which coronary narrowing is responsible for the ischemic obstruction of blood flow to the myocardium, and helps determine which lesions warrant stenting, resulting in improved patient outcomes and reduced health care costs. The examination is usually done during a catheterization procedure with the support of costly pressure wire and hyperemic agent.

Related Links:
Pie Medical Imaging
Erasmus Medical Center

Gold Member
12-Channel ECG
CM1200B
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Medical Examination & Procedure Light
Vega 80
Hybrid Arch Device
Neo EDE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.